[1]
|
Faccia, M., Santopaolo, F., Gasbarrini, A., et al. (2022) Risk Factors for Portal Vein Thrombosis or Venous Thromboembolism in a Large Cohort of Hospitalized Cirrhotic Patients. Internal and Emergency Medicine, 17, 1327-1334. https://doi.org/10.1007/s11739-022-02928-8
|
[2]
|
Rugivarodom, M. and Charatcharoenwitthaya, P. (2020) Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis. Journal of Clinical and Translational Hepatology, 8, 432-444. https://doi.org/10.14218/JCTH.2020.00067
|
[3]
|
Tripodi, A. and Mannucci, P.M. (2011) The Coagulopathy of Chronic Liver Disease. The New England Journal of Medicine, 365, 147-156. https://doi.org/10.1056/NEJMra1011170
|
[4]
|
Wu, H. and Nguyen, G.C. (2010) Liver Cirrhosis Is Associated with Venous Thromboembolism among Hospitalized Patients in a Nationwide US Study. Clinical Gastroenterology and Hepatology, 8, 800-805.E1. https://doi.org/10.1016/j.cgh.2010.05.014
|
[5]
|
Kushner, A., West, W.P., Suheb, M.Z, K., et al. (2024) Virchow Triad. StatPearls, Treasure Island.
|
[6]
|
Turon, F., Driever, E.G., Baiges, A., et al. (2021) Predicting Portal Thrombosis in Cirrhosis: A Prospective Study of Clinical, Ultrasonographic and Hemostatic Factors. Journal of Hepatology, 75, 1367-1376. https://doi.org/10.1016/j.jhep.2021.07.020
|
[7]
|
Nery, F., Correia, S., Macedo, C., et al. (2019) Nonselective Beta-Blockers and the Risk of Portal Vein Thrombosis in Patients with Cirrhosis: Results of A Prospective Longitudinal Study. Alimentary Pharmacology & Therapeutics, 49, 582-588. https://doi.org/10.1111/apt.15137
|
[8]
|
Dong, G., Huang, X., Zhu, Y., et al. (2021) Increased Portal Vein Diameter Is Predictive of Portal Vein Thrombosis Development in Patients with Liver Cirrhosis. Annals of Translational Medicine, 9, Article 289. https://doi.org/10.21037/atm-20-4912
|
[9]
|
McConnell, M.J., Kostallari, E., Ibrahim, S.H. and Iwakiri, Y. (2023) The Evolving Role of Liver Sinusoidal Endothelial Cells in Liver Health and Disease. Hepatology, 78, 649-669. https://doi.org/10.1097/HEP.0000000000000207
|
[10]
|
Takaya, H., Namisaki, T., Asada, S., et al. (2022) ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis Via Hypercoagulability. Journal of Clinical Medicine, 11, Article 1835. https://doi.org/10.3390/jcm11071835
|
[11]
|
Wang, M., Hao, H., Leeper, N.J., et al. (2018) Thrombotic Regulation from the Endothelial Cell Perspectives. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, e90-e95. https://doi.org/10.1161/ATVBAHA.118.310367
|
[12]
|
Lisman, T. and Porte, R.J. (2010) Rebalanced Hemostasis in Patients with Liver Disease: Evidence and Clinical Consequences. Blood, 116, 878-885. https://doi.org/10.1182/blood-2010-02-261891
|
[13]
|
Chen, H., Qi, X., He, C., et al. (2013) Coagulation Imbalance May Not Contribute to the Development of Portal Vein Thrombosis in Patients with Cirrhosis. Thrombosis Research, 131, 173-177. https://doi.org/10.1016/j.thromres.2012.11.003
|
[14]
|
Tang, W., Wang, Y., Zhao, X., et al. (2015) Procoagulant Imbalance Aggravated with Falling Liver Function Reserve, But Not Associated with the Presence of Portal Vein Thrombosis in Cirrhosis. European Journal of Gastroenterology & Hepatology, 27, 672-678. https://doi.org/10.1097/MEG.0000000000000352
|
[15]
|
Fortea, J.I., Carrera, I.G., Puente, Á., et al. (2020) Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders. Journal of Clinical Medicine, 9, Article 2822. https://doi.org/10.3390/jcm9092822
|
[16]
|
Tremblay, D., Naymagon, L., Troy, K., et al. (2020) The Utility of Thrombophilia Testing in Patients with Newly Diagnosed Portal Vein Thrombosis. Blood Coagulation & Fibrinolysis, 31, 213-218. https://doi.org/10.1097/MBC.0000000000000901
|
[17]
|
Fimognari, F.L., De, Santis, A., Piccheri, C., et al. (2005) Evaluation of D-Dimer and Factor VIII in Cirrhotic Patients with Asymptomatic Portal Venous Thrombosis. The Journal of Laboratory and Clinical Medicine, 146, 238-243. https://doi.org/10.1016/j.lab.2005.06.003
|
[18]
|
Fimognari, F.L. and Violi, F. (2008) Portal Vein Thrombosis in Liver Cirrhosis. Internal and Emergency Medicine, 3, 213-218. https://doi.org/10.1007/s11739-008-0128-0
|
[19]
|
Amitrano, L., Anna Guardascione, M., Brancaccio, V., et al. (2004) Risk Factors and Clinical Presentation of Portal Vein Thrombosis in Patients with Liver Cirrhosis. Journal of Hepatology, 40, 736-741. https://doi.org/10.1016/j.jhep.2004.01.001
|
[20]
|
Amitrano, L., Guardascione, M.A., Brancaccio, V., et al. (2002) Portal and Mesenteric Venous Thrombosis in Cirrhotic Patients. Gastroenterological Association, 123, 1409-1410. https://doi.org/10.1053/gast.2002.36391
|
[21]
|
Sogaard, K.K., Astrup, L.B., Vilstrup, H. and Gronbaek, H. (2007) Portal Vein Thrombosis; Risk Factors, Clinical Presentation and Treatment. BMC Gastroenterology, 7, Article No. 34. https://doi.org/10.1186/1471-230X-7-34
|
[22]
|
Sobhonslidsuk, A. and Reddy, K.R. (2002) Portal Vein Thrombosis: A Concise Review. The American Journal of Gastroenterology, 97, 535-541. https://doi.org/10.1111/j.1572-0241.2002.05527.x
|
[23]
|
Condat, B. and Valla, D. (2006) Nonmalignant Portal Vein Thrombosis in Adults. Nature Clinical Practice Gastroenterology & Hepatology, 3, 505-515. https://doi.org/10.1038/ncpgasthep0577
|
[24]
|
Romero-Gömez, M., Gutierrez-Tous, R. and Delgado-Mije, D. (2002) Anticoagulation Therapy for Recent Portal Vein Thrombosis in a Patient with Liver Cirrhosis Suffering from Variceal Rebleeding. Gastroenterological Association, 122, 2095. https://doi.org/10.1053/gast.2002.34024
|
[25]
|
Northup, P.G., Sundaram, V., Fallon, M.B., et al. (2008) Hypercoagulation and Thrombophilia in Liver Disease. Journal of Thrombosis and Haemostasis, 6, 2-9. https://doi.org/10.1111/j.1538-7836.2007.02772.x
|
[26]
|
Bayraktar, Y. and Harmanci, O. (2006) Etiology and Consequences of Thrombosis in Abdominal Vessels. World Journal of Gastroenterology, 12, 1165-1174. https://doi.org/10.3748/wjg.v12.i8.1165
|
[27]
|
Stine, J.G., Wang, J., Shah, P.M., et al. (2018) Decreased Portal Vein Velocity Is Predictive of the Development of Portal Vein Thrombosis: a Matched Case-Control Study. Liver International, 38, 94-101. https://doi.org/10.1111/liv.13500
|
[28]
|
Noronha Ferreira, C., Marinho, R.T., Cortez-Pinto, H., et al. (2019) Incidence, Predictive Factors and Clinical Significance of Development of Portal Vein Thrombosis in Cirrhosis: A Prospective Study. Liver International, 39, 1459-1467. https://doi.org/10.1111/liv.14121
|
[29]
|
Basili, S., Carnevale, R., Nocella, C., et al. (2019) Serum Albumin Is Inversely Associated with Portal Vein Thrombosis in Cirrhosis. Hepatology Communications, 3, 504-512. https://doi.org/10.1002/hep4.1317
|
[30]
|
Yerdel, M.A., Gunson, B., Mirza, D., et al. (2000) Portal Vein Thrombosis in Adults Undergoing Liver Transplantation: Risk Factors, Screening, Management, and Outcome. Transplantation, 69, 1873-1881. https://doi.org/10.1097/00007890-200005150-00023
|
[31]
|
Maruyama, H., Okugawa, H., Takahashi, M., et al. (2013) De novo Portal Vein Thrombosis in Virus-Related Cirrhosis: Predictive Factors and Long-Term Outcomes. The American Journal of Gastroenterology, 108, 568-574. https://doi.org/10.1038/ajg.2012.452
|
[32]
|
Branchford, B.R. and Carpenter, S.L. (2018) The Role of Inflammation in Venous Thromboembolism. Frontiers in Pediatrics, 6, Article 142. https://doi.org/10.3389/fped.2018.00142
|
[33]
|
Hasan, R.A., Koh, A.Y. and Zia, A. (2020) The Gut Microbiome and Thromboembolism. Thrombosis Research, 189, 77-87. https://doi.org/10.1016/j.thromres.2020.03.003
|
[34]
|
Moore, K.L., Andreoli, S.P., Esmon, N.L., et al. (1987) Endotoxin Enhances Tissue Factor and Suppresses Thrombomodulin Expression of Human Vascular Endothelium in Vitro. The Journal of Clinical Investigation, 79, 124-130. https://doi.org/10.1172/JCI112772
|
[35]
|
Whitfield, C. and Trent, M.S. (2014) Biosynthesis and Export of Bacterial Lipopolysaccharides. Annual Review of Biochemistry, 83, 99-128. https://doi.org/10.1146/annurev-biochem-060713-035600
|
[36]
|
Saghazadeh, A. and Rezaei, N. (2016) Inflammation as a Cause of Venous Thromboembolism. Critical Reviews in Oncology/Hematology, 99, 272-285. https://doi.org/10.1016/j.critrevonc.2016.01.007
|
[37]
|
Holstein, K., Matysiak, A., Witt, L., et al. (2020) LPS-Induced Expression and Release of Monocyte Tissue Factor in Patients with Haemophilia. Annals of Hematology, 99, 1531-1542. https://doi.org/10.1007/s00277-020-04075-6
|
[38]
|
Condat, B., Pessione, F., Helene Denninger, M., et al. (2000) Recent Portal or Mesenteric Venous Thrombosis: Increased Recognition and Frequent Recanalization on Anticoagulant Therapy. Hepatology, 32, 466-470. https://doi.org/10.1053/jhep.2000.16597
|
[39]
|
DeLeve, L.D., Valla, D. and Garcia-Tsao, G. (2009) Vascular Disorders of the Liver. Hepatology, 49, 1729-1764. https://doi.org/10.1002/hep.22772
|
[40]
|
Ponziani, F.R., Zocco, M.A., Campanale, C., et al. (2010) Portal Vein Thrombosis: Insight into Physiopathology, Diagnosis, and Treatment. World Journal of Gastroenterology, 16, 143-155. https://doi.org/10.3748/wjg.v16.i2.143
|